Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia (MUTA-GR)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02810496 |
Recruitment Status : Unknown
Verified June 2016 by CHU de Reims.
Recruitment status was: Recruiting
First Posted : June 23, 2016
Last Update Posted : June 23, 2016
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
General Glucocorticoid Resistance | Genetic: blood collection for mutation characterization | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 150 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Basic Science |
Official Title: | Prevalence of Mutations of Glucocorticoid Receptors in Bilateral Adrenal Hyperplasia |
Study Start Date : | April 2012 |
Estimated Primary Completion Date : | December 2016 |

Arm | Intervention/treatment |
---|---|
Experimental: patient |
Genetic: blood collection for mutation characterization |
- frequency of mutations [ Time Frame: DAY 0 ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- patients more than 18 years of age
- patients with bilateral adrenal masses
Exclusion Criteria:
- Refusing to participate in the study
- Protected by law
- Have obvious signs of Cushing's syndrome
- No progressive neoplastic disease

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02810496
Contact: Brigitte DELEMER | 326788101 | bdelemer@chu-reims.fr |
France | |
Chu Reims | Recruiting |
France, Reims, France, 51092 | |
Contact: Damien JOLLY 326788472 ext 33 djolly@chu-reims.fr |
Responsible Party: | CHU de Reims |
ClinicalTrials.gov Identifier: | NCT02810496 |
Other Study ID Numbers: |
PN11010 |
First Posted: | June 23, 2016 Key Record Dates |
Last Update Posted: | June 23, 2016 |
Last Verified: | June 2016 |
Adrenal Hyperplasia, Congenital Adrenogenital Syndrome Hyperplasia Pathologic Processes Disorders of Sex Development Urogenital Abnormalities Congenital Abnormalities |
Genetic Diseases, Inborn Steroid Metabolism, Inborn Errors Metabolism, Inborn Errors Metabolic Diseases Adrenal Gland Diseases Endocrine System Diseases Gonadal Disorders |